Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Recent & Breaking News (TSXV:TLT)

Zacks Small-Cap Research Initiates Coverage on Theralase Technology (TSXV:TLT) (OTCBB:TLTFF) - Video Research Alert on InvestmentPitch.com

Thomson Reuters ONE May 16, 2014

InvestorIntel: Theralase Developing Technology to Stop Cancer Proliferation That Avoids Toxic and Invasive Procedures

Newsfile May 15, 2014

Theralase Partners with Princess Margaret Cancer Centre

TheNewsWire May 15, 2014

Theralase Releases 2013 Financials

TheNewsWire April 30, 2014

Theralase Could Light Up Cancer Therapeutics

Accesswire April 24, 2014

Theralase Anti-Cancer Technology Validated at International Conference

TheNewsWire April 24, 2014

Microcap Report: Theralase (V.TLT) rallies on German conference hopes

Stockhouse Editorial April 22, 2014

Theralase (T.TLT) up 5% on news of German conference demonstration

Stockhouse Editorial April 22, 2014

Theralase Research Accepted at International Conference

TheNewsWire April 22, 2014

InvestorIntel: Share Interest Spurred by Theralase's State-of-the-Art Lasers for the Treatment of Chronic Pain

Newsfile April 15, 2014

Theralase Advances Sales and Marketing

TheNewsWire April 15, 2014

Theralase Technologies (V.TLT) takes next step in anti-cancer tech platform

Stockhouse Editorial April 3, 2014

Secrets of Sports Superstars Who Use the Healing Power of Light

Accesswire April 3, 2014

Theralase Advances Anti-Cancer Technology Platform

TheNewsWire April 3, 2014

Theralase Developing Next Generation Medical Lasers

TheNewsWire March 25, 2014

Theralase CEO to Be Interviewed Today on Clear Channel Business Talk Radio DFW 1190AM

Marketwired March 12, 2014

Theralase Demonstrates Bacteria Destruction in Low Oxygen Environments. Unique Characteristics of New Photo Dynamic Compounds has Application in Destruction of Lung, Breast, Brain, Bladder and Prostate Cancers

TheNewsWire February 13, 2014

Theralase Technologies: Novel Laser Technology for Blockbuster Bladder Cancer Market

Accesswire February 12, 2014

Theralase Releases 3Q2013 Financial Results

TheNewsWire November 29, 2013

Theralase Completes Oversubscribed $3.15 M Equity Financing

TheNewsWire November 7, 2013